• Led commercial planning during 6-year drug development stage of DAXXIFY® • Cultivated relationships with top 50 key opinion leaders in Neurology and Physiatry • Led packaging and brand identity strategy for DAXXIFY®• Led go-to-market strategy (hiring, team leadership, franchise lifecycle) • Oversaw all agency partners including advertising, medical education, and market research • Conceived and led early experience program with 32 expert physicians to identify best practices for new product integration by target customers • Led business development collaborations including the China out-license and partnership • Spearheaded strategic relations with professional and patient organizations • Managed annual business planning including budget, P&L, and sales objectives • Recruited experienced talent to join the marketing, analytics, sales, and finance teams

• Led corporate alliances across 5 therapeutic pillars (ophthalmology, neurology, medical dermatology, urology and aesthetics)• Oversaw initiative to out-license the BOTOX and Ophthalmic franchises in Japan• Coordinated alliance priorities across all internal departments • Led 18 joint steering and development committees• Negotiated over 60 business development agreements, amendments, and terminations

• Grew BOTOX® sales by > 300% (from approx. $200M to over $650M) • Managed P&L for $650M business and supervised the entire marketing department• Led pre-launch and launch efforts for three major growth indications for the BOTOX® franchise• Maintained 94% market share for BOTOX® in the face of aggressive new competitive entrants• Directed the investment of a $30M promotional budget

Director for three national field teams (total staff of 70) with BOTOX® reimbursement and hospital sales focus• Oversaw Medicare / Medicaid market access team to ensure optimal coverage and coding• Directed field reimbursement team which assisted more than 1500 medical practices • Led hospital and institution sales team targeting resident and fellowship programs